Kungshusen Medicinska has been acquired by Diploma
Kungshusen Medicinska AB has been acquired by Diploma PLC. Through the acquisition, Diploma gains access to a unique platform for the distribution of medtech products in Sweden.
Founded in 1977, Kungshusen is a leading Swedish distributor of medtech products in endoscopy and diathermy. The company has established a solid supplier network comprising leading international manufacturers of high-quality products and has built a strong reputation in the market based on its one-stop shop offering, high deliverability and vast sector experience. Headquartered in Mariefred, Kungshusen serves healthcare providers in all major regions of Sweden. Kungshusen’s revenues amount to approximately US$14 million.
Diploma is a UK-listed international group supplying specialized products and services within seals, controls and life sciences. Within the life sciences segment, the company supplies clinical diagnostics instruments and surgical medical devices to hospitals, clinics and laboratories, primarily in Canada, Europe and Australia. Diploma’s revenues amount to approximately US$740 million.
Oaklins’ Swedish team was engaged to run a structured sale process and advised the seller throughout the transaction.
CEO and Co-owner, Kungshusen Medicinska AB
Talk to the deal team
Managing PartnerStockholm, Sweden
East West Eye Institute has been acquired by NVISION Eye Centers
East West Eye Institute (EWEI), one of the largest independent eyecare platforms in California, has sold a majority interest to Nvision Eye Centers, one of the larger providers of comprehensive eyecare, LASIK and cataract surgery services in the USA.Learn more
UAB MediCA klinika has acquired UAB Varpo seimos klinika
UAB MediCA klinika has acquired UAB Varpo seimos klinika.Learn more
ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.Learn more